請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68434
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 宋麗英(Li-Ying Sung) | |
dc.contributor.author | Tzu-Ying Lin | en |
dc.contributor.author | 林姿穎 | zh_TW |
dc.date.accessioned | 2021-06-17T02:20:56Z | - |
dc.date.available | 2017-08-24 | |
dc.date.copyright | 2017-08-24 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-08-20 | |
dc.identifier.citation | A. Gregory Matera and Zefeng Wang. (2014) A day in the life of the spliceosome. Nature 15, 108-121.
Aaron R. Poole and Michael D. Hebert. (2016) SMN and coilin negatively regulate dyskerin association with telomerase RNA. Biol. Open 5, 726-735. Ahmad, S., Bhatia, K., Kannan, A., and Gangwani, L. (2016) Molecular mechanisms of neurodegeneration in spinal muscular atrophy. J. Exp. Neurosci. 10, 39-49. Akamine, R., Yamamoto, T., Watanabe, M., Yamazaki, N., Kataoka, M., Ishikawa, M., Ooie, T., Baba, Y., and Shinohara, Y. (2007) Usefulness of the 5' region of the cDNA encoding acidic ribosomal phosphoprotein P0 conserved among rats, mice and humans as a standard probe for gene expression analysis in different tissues and animal species. J. Biochem. Biophys. Methods 70, 481-486. Allison D. Ebert and Clive N. Svendsen. (2010) Stem cell model of spinal muscular atrophy. Arch Neurol. 67, 665-669. Aloicia Schmid and Christine J. DiDonato. (2007) Animal models of spinal muscular atrophy. J. Child Neurol. 22, 1004-1012. Arthur H.M. Burghes and Christine E. Beattie. (2009) Spinal muscular atrophy: Why do low level of SMN make motor neurons sick? Nat. Rev. Neurosci. 10, 597-609. Avilion, A.A., Nicolis, S.K., Pevny, L.H., Perez, L., Vivian, N., and Lovell-Badge, R. (2003) Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 17, 126-140. Bachand, F., Boisvert, F.M., Côté, J., Richard, S., and Autexier, C. (2002) The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Mol. Biol. Cell 13, 3192-3202. Barker, T.H., Grenett, H.E., MacEwen, M.W., Tilden, S.G., Fuller, G.M., Settleman, J., Woods, A., Murphy-Ullrich, J., and Hagood, J.S. (2004) Thy-1 regulates fibroblast focal adhesions, cytoskeletal organization and migration through modulation of p190 RhoGAP and Rho GTPase activity. Exp. Cell Res. 295, 488-496. Bertram Wiedenmann and Werner W. Franke. (1985) Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles. Cell 41, 1017-1028. Boulares, A.H., Yakovlev, A.G., Ivanova, V., Stoica, B.A., Wang, G., Iyer, S., and Smulson, M. (1999) Role of poly(ADP-ribose) polymerase (PARP) cleavage in apoptosis: caspase 3-resistant PARP mutant increases rates of apoptosis in transfected cells. J. Biol. Chem. 274, 22932-22940. Brambrink, T., Foreman, R., Welstead, G.G., Lengner, C.J., Wernig, M., Suh, H., and Jaenisch, R. (2008) Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2, 151-159. Briggs, R. and King, T.J. (1952) Transplantation of living nuclei from blastula cells into enucleated frogs’ eggs. Proc. Natl Acad. Sci. 38, 455-463. Brunhilde Wirth. (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat. 15, 228-237. Buganim, Y., Faddah, D.A., Cheng, A.W., Itskovich, E., Markoulaki, S., Ganz, K., Klemm, S.L., van Oudenaarden, A., and Jaenisch, R. (2012) Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell 150, 1209-1222. Burghes, A.H., Ingraham, S.E., McLean, M., Thompson, T.G., McPherson, J.D., Kote-Jarai, Z., Carpten, J.D., DiDonato, C.J., Ikeda, J.E., Surh, L., et al. (1994) A multicopy dinucleotide marker that maps close to the spinal muscular atrophy gene. Genomics 21, 394-402. Burlet, P., Huber, C., Bertrandy, S., Ludosky, M.A., Zwaenepoel, I., Clermont, O., Roume, J., Delezoide, A.L., Cartaud, J., Munnich, A., and Lefebvre, S. (1998) The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum. Mol. Genet. 7, 1927-1933. Campbell, K.H., McWhir, J., Ritchie, W.A. and Wilmut, I. (1996) Sheep cloned by nuclear transfer from a cultured cell line. Nature 380, 64-66. Campbell, L., Potter, A., Ignatius, J., Dubowitz, V., and Davies, K. (1997) Genomic variation and gene conversion in spinal muscular atrophy: implications for disease process and clinical phenotype. Am. J. Hum. Genet. 61, 40-50. Catapano, F., Zaharieva, I., Scoto, M., Marrosu, E., Morgan, J., Muntoni, F., and Zhou, H. (2016) Altered levels of microRNA-9, -206, and -132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy. Mol. Ther. Nucleic Acids 5, e331. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., and Smith, A. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655. Chin, M.H., Mason, M.J., Xie, W., Volinia, S., Singer, M., Peterson, C., Ambartsumyan, G., Aimiuwu, O., Richter, L., Zhang, J., Khvorostov, I., Ott, V., Grunstein, M., Lavon, N., Benvenisty, N., Croce, C.M., Clark, A.T., Baxter, T., Pyle, A.D., Teitell, M.A., Pelegrini, M., Plath, K., and Lowry, W.E. (2009) Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 5, 111-123. Chiou, S.H., Jiang, B.H., Yu, Y.L., Chou, S.J., Tsai, P.H., Chang, W.C., Chen, L.K., Chen, L.H., Chien, Y., and Chiou, G.Y. (2013) Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc. J. Exp. Med. 210, 85-98. Chun, Y.S., Byun, K., and Lee, B. (2011) Induced pluripotent stem cells and personalized medicine: current progress and future perspectives. Anat. Cell Biol. 44, 245-255. Cindy L. Will and Reinhard Lührmann. (2001) Spliceosomal UsnRNP biogenesis, structure and function. Curr. Opin. Cell Biol. 13, 290-301. Coady, T.H. and Lorson, C.L. (2011) SMN in spinal muscular atrophy and snRNP biogenesis. Wiley Interdiscip. Rev. RNA. 2, 546-564. Coovert, D., Le, T.T., McAndrew, P., Strasswimmer, J., Crawford, T.O., Mendell, J.R., Coulson, S., Androphy, E.J., Prior, T.W., and Burghes, A.H.M. (1997) The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6, 1205-1214. Corti, S., Nizzardo, M., Nardini, M., Donadoni, C., Salani, S., Ronchi, D., Saladino, F., Bordoni, A., Fortunato, F., Del Bo, R., Papadimitriou, D., Locatelli, F., Menozzi, G., Strazzer, S., Bresolin, N., and Comi, G.P. (2008) Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy. J. Clin. Invest. 118, 3316-3330. Da Silva, J.S., Medina, M., Zuliani, C., Di Nardo, A., Witke, W., and Dotti, C.G. (2003) RhoA/ROCK regulation of neuritogenesis via prolin IIa-mediated control of actin stability. J Cell Biol. 162, 1267-1279. Dantzer, F., Amé, J.C., Schreiber, V., Nakamura, J., Ménissier-de Murcia, J., and de Murcia, G. (2006) Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair. Methods Enzymol. 409, 493-510. Doege, C.A., Inoue, K., Yamashita, T., Rhee, D.B., Travis, S., Fujita, R., Guarnieri, P., Bhagat, G., Vanti, W.B., Shih, A., Levine, R.L., Nik, S., Chen, E.I., and Abeliovich, A. (2012) Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 488, 652-655. Ebert, A.D., Yu, J., Rose Jr, F.F., Mattis, V.B., Lorson, C.L., Thomson, J.A., and Svendsen, C.N. (2009) Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature 457, 277-280. Eggert, C., Chari, A., Laggerbauer, B., and Fischer, U. (2006) Spinal muscular atrophy: the RNP connection. Trends Mol. Med. 12, 113-121. Eleanor T. Coffey. (2014) Nuclear and cytosolic JNK signalling in neurons. Nat Rev Neurosci. 15, 285-299. Emmanuel Culetto and David B. Sattelle. (2000) A role for Caenorhabditis elegans in understanding the function and interactions of human disease genes. Hum. Mol. Genet. 9, 869-877. Evans, M.J. and Kaufman, M.H. (1981) Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154-156. Fischer, U., Liu, Q., and Dreyfuss, G. (1997) The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 90, 1023-1029. Frugier, T., Tiziano, F.D., Cifuentes-Diaz, C., Miniou, P., Roblot, N., Dierich, A., Le Meur, M., and Melki, J. (2000) Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 9, 849-858. Fuller, H.R., Mandefro, B., Shirran, S.L., Gross, A.R., Kaus, A.S., Botting, C.H., Morris, G.E., and Sareen, D. (2016) Spinal muscular atrophy patient iPSC-derived motor neurons have reduced expression of proteins important in neuronal development. Front. Cell Neurosci. 9, 506. doi: 10.3389/fncel.2015.00506. eCollection 2015. Gabanella, F.,. Butchbach, M.E.R., Saieva, L., Carissimi, C., Burghes, A.H.M., and Pellizzoni, L. (2007) Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS ONE 2:e921. Genevieve Gowing and Clive N. Svendsen. (2011) Stem cell transplantation for motor neuron disease: current approaches and future perspective. Neurotherapeutics 8, 591-606. Govek, E.E., Newey, S.E., and Van Aelst, L. (2005) The role of the Rho GTPases in neuronal development. Genes Dev. 19, 1-49. Grice S.J. and Liu, J.L. (2011) Survival motor neuron protein regulates stem cell division, proliferation, and differentiation in Drosophila. PLoS Genet.7(4):e1002030. Gubitz, A.K., Feng, W., and Dreyfuss, G. (2004) The SMN complex. Exp. Cell Res. 296, 51-56. Gurdon, J.B. (1962) The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles. J. Embryol. Exp. Morph. 10, 622-640. Hanna, J., Saha, K., Pando, B., van Zon, J., Lengner, C.J., Creyghton, M.P., van Oudenaarden, A., and Jaenisch, R. (2009) Direct cell reprogramming is a stochastic process amenable to acceleration. Nature 462, 595-601. Hannus, S., Buhler, D., Romano, M., Seraphin, B., and Fischer, U. (2000) The Schizosaccharomyces pombe protein Yab8p and a novel factor, Yip1p, share structural and functional similarity with the spinal muscular atrophy-associated proteins SMN and SIP1. 9, 663-674. Hemberger, M., Nozaki, T., Winterhager, E., Yamamoto, H., Nakagama, H., Kamada, N., Suzuki, H., Ohta, T., Ohki, M., Masutani, M., and Cross, J.C. (2003) Parp1-deficiency induces differentiation of ES cells into trophoblast derivatives. Dev. Biol. 257, 371-381. Henderson, J.K., Draper, J.S., Baillie, H.S., Fishel, S., Thomson, J.A., Moore, H., and Andrews, P.W. (2002) Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 20, 329-337. Hsieh-Li, H., Chang, J.G., Jong, Y.J., Wu., M.H., Wang, N., Tsai, C.H., and Li, H. (2000) A mouse model for spinal muscular atrophy. Nat. Genet. 24, 66-70. Jangi, M., Fleet, C., Cullen, P., Gupta, S.V., Mekhoubad, S., Chiao, E., Allaire, N., Bennett, C.F., Rigo, F., Krainer, A.R., Hurt, J.A., Carulli, J.P., and Staropoli, J.F. (2017) SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage. Proc. Natl. Acad. Sci. 114, E2347-E2356. Jiang, B.H., Chen, W.Y., Li, H.Y., Chien, Y., Chang, W.C., Hsieh, P.C., Wu, P., Chen, C.Y., Song, H.Y., Chien, C.S., Sung, Y.J., and Chiou, S.H. (2015) CHD1L regulated PARP1-driven pluripotency and chromatin Remodeling during the early-stage cell reprogramming. Stem Cells 33, 2961-2972. Jordan, T., Hanson, I., Zaletayev, D., Hodgson, S., Prosser, J., Seawright, A., Hastie, N., and van Heyningen, V. (1992) The human PAX6 gene is mutated in two patients with aniridia. Nat. Genet. 1, 328-332. Jorge Laborda. (1991) 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein P0. Nucleic Acids Research 19, 3998. Joseph G. Gall. (2003) The centennial of the Cajal body. Nat. Rev. Mol. Cell Biol. 4, 975-980. Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010). Kugelberg, E and Welander, L. (1956) Heredofamilial juvenile muscular atrophy simulating muscular dystrophy. AMA. Arch. Neurol. Psychiatry 75, 500. Kun, E., Kirsten, E., Bauer, P.I., and Ordahl, C.P. (2006) Quantitative correlation between cellular proliferation and nuclear poly (ADP-ribose) polymerase (PARP-1). Int. J. Mol. Med. 17, 293-300. Lai, Y.S., Chang, C.W., Pawlik, K.M., Zhou, D., Renfrow, M.B., and Townes, T.M. (2012) SRY (sex determining region Y)-box2 (Sox2)/poly ADP-ribose polymerase 1 (Parp1) complexes regulate pluripotency. Proc. Natl. Acad. Sci. 109, 3772-3777. Lee, L., Davies, S.E., and Liu, J.L. (2009) The spinal muscular atrophy protein SMN affects Drosophila germline nuclear organization through the U body-P body pathway. Dev. Biol. 332, 142-155. Lefebvre, S., Burglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., Paslier, D.L., Frezal, J., Cohen, D., Weissenbach, J., Munnich, A., and Melki, J. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165. Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, P., Cruaud, C., Millasseau, P., and Zeviani, M. (1995) Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80, 155-165. Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., and Melki, J. (1997) Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16, 265-269. Li, D.K., Tisdale, S., Lotti, F., and Pellizzoni, L. (2014) SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease. Semin. Cell Dev. Biol. 32, 22-29. Li, R., Liang, J., Ni, S., Zhou, T., Qing, X., Li, H., He, W., Chen, J., Li, F., Zhuang, Q., Qin, B., Xu, J., Li, W., Yang, J., Gan, Y., Qin, D., Feng, S., Song, H., Yang, D., Zhang, B., Zeng, L., Lai, L., Esteban, M.A., and Pei, D.(2010) A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell 7, 51-63. Li, Y., Chan, L., Nguyen, H.V., and Tsang, S.H. (2016) Personalized medicine: cell and gene therapy based on patient-specific iPSC-derived retinal pigment epithelium cells. Adv. Exp. Med. Biol. 854, 549-555. Ling, K.K., Gibbs, R.M., Feng, Z., and Ko, C.P. (2012) Severe neuromuscular denervation of clinically relevant muscles in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 21, 185-195. Liu, H., Shafey, D., Moores, J.N., and Kothary, R. (2010) Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy, J. Neurosci. Res. 88, 111-122. Lorson, C.L., Hahnen, E., Androphy, E.J., and Wirth, B. (1999) A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. 11, 6307-6311. Lotti, F., Imlach, W.L., Saieva, L., Beck, E.S., Hao, L.T., Li, D.K., Jiao, W., Mentis, G.Z., Beattie, C.E., McCabe, B.D., and Pellizzoni, L. (2012) An SMN-dependent U12 splicing event essential for motor circuit function. Cell 151, 440-454. Maekawa, M., Yamaguchi, K., Nakamura, T., Shibukawa, R., Kodanaka, I., Ichisaka, T., Kawamura, Y., Mochizuki, H., Goshima, N., and Yamanaka, S. (2011) Direct reprogramming of somatic cells is promoted by maternal transcriptional factor Glis1. Nature 474, 225-229. McAndrew, P.E., Parsons, D.W., Simard, L.R., Rochette, C., Ray, P.N., Mendell, J.R., Prior, T.W., and Burghes, A.H. (1997) Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am. J. Hum. Genet. 60, 1411-1422. McWhorter, M.L., Monani, U.R., Burghes, A.H.M., and Beattie, C.E. (2003) Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919-931. Meyer, K., Miranda, C.J., and Kaspar, B.K. (2013) Transplantation of gene-corrected Motor neurons as a therapeutic strategy for spinal muscular atrophy. Mol. Ther. 21, 502-503. Miguel-Aliaga, I., Culetto, E., Walker, D.S., Baylis, H.A., Satelle, D.B., and Davies, K.E. (2000) The Caenorhabditis elegans orthologue of the human SMN gene responsible for spinal muscular atrophy is a maternal product critical for germline maturation and embryonic viability. Hum. Mol. Genet. 8, 2133-2143. Mitsui, K., Tokuzawa, Y., Segawa, K., Murakami, M., Takahashi, K., Maeda, M., and Yamanaka, S. (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642. Monani, U.R., Coovert, D.D., and Burghes, A.H.M. (2000) Animal models of spinal muscular atrophy. Hum. Mol. Genet. 9, 2451-2457. Monani, U.R., Lorson, C.L., Parsons, D.W., Prior, T.W., Androphy, E.J., Burghes, A.H., and McPherson, J.D. (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8, 1177-1183. Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossoll, W., Prior, T.W., Morris, G.E., and Burghes, A.H.M. (2000) The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn–/– mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9, 333-339. Nagy, A., Rossant, J., Nagy, R., Abramow-Newerly, W., and Roder, J.C. (1993) Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc. Natl. Acad. Sci. 90, 8424-8428. Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., and Yamanaka, S. (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106. Neil Chi and Jonathan A. Epstein. (2002) Getting your Pax straight: Pax proteins in development and disease. Trends Genet. 18, 41-47. Ng, S.Y., Soh, B.S., Rodriguez-Muela, N., Hendrickson, D.G., Price, F., Rinn, J.L., and Rubin, L.L. (2015) Genome-wide RNA-Seq of human motor neurons implicates selective ER stress activation in spinal muscular atrophy. Cell Stem Cell 17, 569-584. Nichols, J., Zevnik, B., Anastassiadis, K., Niwa, H., Klewe-Nebenius, D., Chambers, I., Schöler, H., and Smith, A. (1998) Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell 95, 379-391. Nizzardo, M., Simone, C., Dametti, S., Salani, S., Ulzi, G., Pagliarani, S., Rizzo, F., Frattini, E., Pagani, F., Bresolin, N., Comi, G., and Corti, S. (2015) Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches. Sci. Rep. 5, 11746. O’Connor, M.D., Kardel, M.D., Iosfina, I., Youssef, D., Lu, M., Li, M.M., Vercauteren, S., Nagy, A., and Eaves, C.J. (2008) Alkaline phosphatase-positive colony formation is a sensitive, specific, and quantitative indicator of undifferentiated human embryonic stem cells. Stem Cells 26, 1109-1116. Okita, K., Ichisaka, T., and Yamanaka, S. (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317. Ottesen, E.W., Howell, M.D., Singh, N.N., Seo, J., Whitley, E.M., and Singh, R.N. (2016) Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy. Sci. Rep. 6:20193. Owen, N., Doe, C.L., Mellor, J., and Davies, K.E. (2000) Characterization of the Schizosaccharomyces pombe orthologue of the human survival motor neuron (SMN) protein. Hum. Mol. Genet. 9, 675-684. Palmqvist, L., Glover, C.H., Hsu, L., Lu, M., Bossen, B., Piret, J.M., Humphries, R.K., and Helgason, C.D. (2008) Correlation of murine embryonic stem cell gene expression profiles with functional measures of pluripotency. Stem Cells 23, 663-680. Panagiotis Papasaikas and Juan Valcárcel. (2016) The Spliceosome: The ultimate RNA chaperone and sculptor. Trends Biochem. Sci. 41, 33-45. Pellizzoni, L., Baccon, J., Charroux, B., and Dreyfuss, G. (2001) The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1. Curr. Biol. 21, 1079-1088. Pellizzoni, L., Kataoka, N., Charroux, B., and Dreyfuss, G. (1998) A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95, 615-624. Pellizzoni, L., Yong, J., and Dreyfuss, G. (2002) Essential role for the SMN complex in the specificity of snRNP assembly. Science 298, 1775-1779. Poirier, G.G., Murcia, G.D., Jongstra-Bilen, J., Niedergang, C., and Mandel, P. (1982) Poly(ADP-ribosyl)ation of polynucleosomes causes relaxation of chromatin structure. Proc. Natl. Acad. Sci. 79, 3423-3427. Polo, J.M., Anderssen, E., Walsh, R.M., Schwarz, B.A., Nefzger, C.M., Lim, S.M., Borkent, M., Apostolou, E., Alaei, S., Cloutier, J., Bar-Nur, O., Cheloufi, S., Stadtfeld, M., Figueroa, M.E., Robinton, D., Natesan, S., Melnick, A., Zhu, J., Ramaswamy, S., and Hochedlinger, K. (2012) A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 151, 1617-1632. Pralong, D., Trounson, A.O., and Verma, P.J. (2006) Cell fusion for reprogramming pluripotency: Toward elmination of the pluripotent genome. Stem Cell Rev. 2, 331-340. Qing Liu and Gideon Dreyfuss. (1996) A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15, 3555-3565. Rajendra, T.K., Gonsalvez, G.B., Walker, M.P., Shpargel, K.B., Salz, H.K., and Matera, A.G. (2007) A Drosophila melanogaster model of spinal muscular atrophy reveals a function for SMN in striated muscle. J. Cell Biol. 176, 831-841. Ramsden, C.M., Powner, M.B., Carr, A.J., Smart, M.J., da Cruz, L., and Coffey, P.J. (2013) Stem cells in retinal regeneration: past, present and future. Development 140, 2576-2585. Rege, T.A. and Hagood, J.S. (2006) Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 20, 1045-1054. Renvoisé, B., Khoobarry, K., Gendron, M.C., Cibert, C., Viollet, L., and Lefebvre, S. (2006) Distinct domains of the spinal muscular atrophy protein SMN are required for targeting to Cajal bodies in mammalian cells. J. Cell Sci. 119, 680-692. Reubinoff, B.E., Pera, M.F., Fong, C.Y., Trounson, A., and Bongso, A. (2000) Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. 18:399-404. Richard P. Tucker. (1990) The role of microtubule-associated proteins in brain morphogenesis: a review. Brain Res. Brain Res. Rev. 15, 101-120. Roper, S.J., Chrysanthou, S., Senner, C.E., Sienerth, A., Gnan, S., Murray, A., Masutani, M., Latos, P., and Hemberger, M. (2014) ADP-ribosyltransferases Parp1 and Parp7 safeguard pluripotency of ES cells. Nucleic Acids Res. 42, 8914-8927. Rossoll, W., Jablonka, S., Andreassi, C., Kröning, A.K., Karle, K., Monani, U.R., and Sendtner, M. (2003) Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons, J. Cell Biol. 163, 801-812. Sakaki-Yumoto, M., Kobayashi, C., Sato, A., Fujimura, S., Matsumoto, Y., Takasato, M., Kodama, T., Aburatani, H., Asashima, M., Yoshida, N., and Nishinakamura, R. (2006) The murine homolog of SALL4, a causative gene in Okihiro syndrome, is essential for embryonic stem cell proliferation, and cooperates with Sall1 in anorectal, heart, brain and kidney development. Development 133, 3005-3013. Samavarchi-Tehrani, P., Golipour, A., David, L., Sung, H.K., Beyer, T.A., Datti, A., Woltjen, K., Nagy, A., and Wrana, J.L. (2010) Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell 7, 64-77. Sanchez, G., Dury, A.Y., Murray, L.M., Biondi, O., Tadesse, H., Fatimy, R.E., Kothary, R., Charbonnier, F., Khandjian, E.W., and Côté, J. (2012) A novel function for the survival motoneuron protein as a translational regulator. Hum. Mol. Genet. 22, 668-684. Schrank, B., Götz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith, A.G., and Sendtner, M. (1997) Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl. Acad. Sci. U.S.A 94, 9920-9925. Seo, J., Singh, N.N., Ottesen, E.W., Lee, B.M., and Singh, R.N. (2016) A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein, Sci. Rep. 6, 30778. Setola, V., Terao, M., Locatelli, D., Bassanini, S., Garattini, E., and Battaglia, G. (2007) Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis, Proc. Natl. Acad. Sci. 104, 1959-1964. Shinya Yamanaka. (2009) Elite and stochastic models for induced pluripotent stem cell generation. Nature 460, 49-52. Singh, R.N., Howell, M.D., Ottesen, E.W., and Singh, N.N. (2017) Diverse role of survival motor neuron protein. Biochim. Biophys. Acta. 1860, 299-315. Sleigh, J.N., Gillingwater, T.H., and Kevin Talbot, K. (2011) The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy. Dis. Model Mech. 4, 457-467. Solter, D. and Knowles, B.B. (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc. Natl. Acad. Sci. 75, 5565-5569. Stadtfeld, M., Maherali, N., Breault, D.T., and Hochedlinger, K. (2008) Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230-240. Sungchan Cho and Gideon Dreyfuss. (2010) A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev. 24, 438-442. Tachibana, M., Amato, P., Sparman, M., Gutierrez, N.M., Tippner-Hedges, R., Ma, H., Kang, E., Fulati, A., Lee, H.S., Sritanaudomchai, H., Masterson, K., Larson, J., Eaton, D., Sadler-Fredd, K., Battaglia, D., Lee, D., Wu, D., Jensen, J., Patton, P., Gokhale, S., Stouffer, R.L., Wolf, D., and Mitalipov, S. (2013) Human embryonic stem cells derived by somatic cell nuclear transfer. Cell 153, 1228-1238. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N., and Tada, T. (2001) Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 11, 1553-1558. Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., and Rao, A. (2009) Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. 126, 663-676. Thomas W. Prior. (2007) Spinal muscular atrophy diagnostics. J. Child Neurol. 22, 952-956. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., and Jones, J.M. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282,1145-1147. Trounson, A. and DeWitt, N.D. (2016) Pluripotent stem cells progressing to the clinic. Nat. Rev. Mol. Cell Biol. Wang, J., Rao, S., Chu, J., Shen, X., Levasseur, D.N., Theunissen, T.W., and Orkin, S.H. (2006) A protein interaction network for pluripotency of embryonic stem cells. Nature 444, 364-368. Weber, F.A., Bartolomei, G., Hottiger, M.O., and Cinelli, P. (2013) Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation. Stem Cells 31, 2364-2373. Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B.E., and Jaenisch, R. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448, 318-324. Wertz, M.H., Winden, K., Neveu, P., Ng, S.Y., Ercan, E., and Sahin, M. (2016) Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy. Hum. Mol. Genet. 25, 2168-2181. Wichterle, H., Lieberam, I., Porter, J.A., and Jessell, T.M. (2002) Directed differentiation of embryonic stem cells into motor neurons. Cell 110, 385-397. Yoshida, M., Kitaoka, S., Egawa, N., Yamane, M., Ikeda, R., Tsukita, K., Amano, N., Watanabe, A., Morimoto, M., Takahashi, J., Hosoi, H., Nakahata, T., Inoue, H., and Saito, M.K. (2015) Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs. Stem Cell Reports 4, 561-568. Yu, J., Vodyanik, M.A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J.L., Tian, S., Nie, J., Jonsdottir, G.A., Ruotti, V., Stewart, R., Slukvin, I.I., and Thomson, J.A. (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920. Zhang, J., Tam, W.L., Tong, G.Q., Wu, Q., Chan, H.Y., Soh, B.S., Lou, Y., Yang, J., Ma, Y., Chai, L., Ng, H.H., Lufkin, T., Robson, P., and Lim, B. (2006) Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat. Cell Biol. 8, 1114-1123. Zhang, R., So, B.R., Li, P., Yong, J., Glisovic, T., Wan, L., and Dreyfuss, G. (2011) Structure of a key intermediate of the SMN complex reveals Gemin2's crucial function in snRNP assembly. Cell 146, 384-395. Zhang, Z., Lotti, F., Dittmar, K., Younis, I., Wan, L., Kasim, M., and Dreyfuss, G. (2008) SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133, 585-600. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/68434 | - |
dc.description.abstract | 運動神經元存活蛋白 (Survival motor neuron, SMN) 是一種廣泛存在於多種細胞內,並參與小核核糖核蛋白 (small nuclear ribonucleoprotein, snRNP) 與RNA剪接體 (RNA spliceosome) 生合成之重要蛋白質;此外,SMN亦參與基因轉錄轉譯調控、端粒酶 (telomerase)生合成與細胞內物質運輸等功能。SMN基因高度保留於各不同物種間,當人體因SMN1基因缺失或突變、導致SMN蛋白質功能不全,而引發脊髓性肌肉萎縮症 (spinal muscular atrophy, SMA) ,此病症為前角運動神經元 (anterior horn motor neuron) 發生漸進性退化,導致肌肉逐漸軟弱無力的一種體染色體隱性遺傳疾病。罹患此症者,通常會出現運動神經元退化、肌肉無力與萎縮等症狀;嚴重者可能出現肌張力退減、吞嚥困難甚而呼吸衰竭致死。除了其於神經細胞上扮演之重要角色外,近年研究亦指出SMN與未分化幹細胞之關聯性:SMN大量表現於果蠅之神經幹細胞與生殖幹細胞,隨著子細胞分化而呈現梯度將低;當SMN表現受抑制會造成果蠅發育障礙,過度表現則可延緩細胞分化。在哺乳動物模式中,小鼠著床前胚胎與胚胎幹細胞 (embryonic stem cells, ESCs) 皆表現大量SMN,以維持胚胎正常發育與胚胎幹細胞潛能。SMN基因剔除 (gene knockout) 具有胚致死性,使小鼠早期胚胎因細胞大量死亡而無法順利著床;此外,部分缺乏SMN之胚胎幹細胞,其維持幹細胞潛能之重要因子表現量會隨之降低、誘發細胞分化之訊息上升、後續阻礙神經分化;反之,過度表現SMN則有助於胚胎幹細胞之分化抗性。以上研究皆闡釋了SMN於細胞發育、增生與分化,以及幹細胞潛能維持之重要性,使我們提出了SMN可能影響體細胞再程序化過程之假說。誘導型多能性幹細胞 (induced pluripotent stem cells, iPSCs) 為一種近似胚胎幹細胞、具有多能分化潛力之細胞;利用過度表現特定再程序化因子 (reprogramming factor) 可將已分化之體細胞再程序化為未分化狀態。研究指出小鼠卵子中含有大量SMN,而胚胎纖維母細胞 (mouse embryonic fubroblasts, MEFs) 與分化末端之神經細胞僅表現低量SMN;基於卵細胞含有許多未知再程序化因子之前提下,更加深了SMN可能具有提升體細胞再程序化效率之潛力。本研究目的係為探討SMN於體細胞再程序化過程及神經細胞分化所扮演之角色。試驗結果顯示,SMN於體細胞再程序化過程中表現量大幅提升,並於誘導型多能性幹細胞中具有相似於胚胎幹細胞之表現量。將Smn與特定再程序化因子共同表現於體細胞,可以加速誘導型多能性幹細胞形成,同時有效增加細胞產製數量。使用SMA模式小鼠之成體纖維母細胞進行體細胞再程序化,發現低量SMN阻礙了再程序化與誘導型多能性幹細胞產製。SMA小鼠產製之誘導型多能性幹細胞中,其多能性幹細胞重要因子包含 Oct4, Sox2, Klf4, Sall4及 Rex1 之表現量皆顯著下降,由該細胞分化之成熟神經細胞數量亦減少,特定神經細胞標的蛋白如 PAX6, MAP2 及 TUJ1 表現量受抑制。此試驗結果與前述缺乏SMN表現之胚胎幹細胞相呼應。最後,我們在SMA誘導型多能性幹細胞中強制表現SMN,發現多能性幹細胞重要因子之RNA表現量隨之提升,神經細胞分化狀況亦有所改善;然而多能性幹細胞重要因子之蛋白質表現量卻呈現趨勢下降,此部分仍待進一步瞭解。綜上所述,SMN於體細胞再程序化中扮演重要角色,有助於提升SMA細胞再程序化效率與神經分化潛能。 | zh_TW |
dc.description.abstract | Survival motor neuron (SMN) is an essential protein plays important roles in the assembly of small nuclear ribonucleoproteins (snRNPs), the components of the RNA spliceosome, and other functions include transcriptional regulation and cellular trafficking. From the aspect of evolution, SMN gene is highly conserved through diverse species and keeps fundamental functions. Deficiency of the ubiquitous SMN protein causes spinal muscular atrophy (SMA), a leading genetic cause of infant death and one of the most common autosomal recessive diseases. In addition to the roles in neuron cells, recent studies have linked the connection between SMN and stem cell potency. We and others showed that SMN regulates stem cell pluripotency, division, proliferation and differentiation in Drosophila and mouse model. On the other hand, SMN is abundantly expressed in mouse oocytes and embryonic stem cells, but low in mouse embryonic fibroblast cells (MEFs) and neurons. Therefore, we hypothesize that SMN may play important roles during the reprogramming process of induced pluripotent stem cell (iPSC) formation. The objective of this study is to examine the roles of SMN in cellular reprogramming and neuronal differentiation in normal and SMA cells. The results showed that SMN was up-regulated during the induced pluripotency reprogramming process by OSKM (Oct4, Sox2, Klf4, and cMyc) factors when ICR and C57BL/6s WT mouse MEFs were used, along with the typical pluripotency markers including Nanog, Oct4 and SSEA1. Over-expression of SMN in WT cells improved the iPSC formation efficiency as judged by real-time PCR and alkaline phosphatase (AP) activity; whereas knocking-down of SMN completely abolished the iPSC formation. Consistently, iPSC formation efficiency using SMA mouse tail-tip fibroblasts (TTFs) was extremely low, along with impaired pluripotent genes expression, including Oct4, Sox2, Klf4, Sall4 and Rex1. Reduced SMN also delayed neuronal differentiation when compared to those with normal SMN level. Finally, over-expression of SMN in SMA tail-tip fibroblasts improved the pluripotent genes expression in iPSC as well as the neurite in vitro differentiation. These findings indicate that SMN plays important roles during cellular reprogramming and neuronal differentiation. | en |
dc.description.provenance | Made available in DSpace on 2021-06-17T02:20:56Z (GMT). No. of bitstreams: 1 ntu-106-R04642004-1.pdf: 21887579 bytes, checksum: 13a837ae914309990f14e0ebf6be1cbc (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | 口試委員會審定書 I
致謝 II 中文摘要 III Abstract IV Contents V List of Figures VI List of Tables VII Abbreviations VIII Literature Review 1 A. Multifunctions of SMN protein in animal kingdom 1 B. SMN and SMA disease 3 C. SMA animal model 7 D. SMN and stem cell potency 9 E. Nuclear reprogramming of somatic cells 10 Perspectives 13 Materials and Methods 14 A. Experimental design 14 B. Animals 18 C. Mouse blastocyst vitrification, thawing and embryo transfer 18 D. Cell culture 20 E. Induced pluripotent stem cell induction 22 F. Infection of iPSC with SMN over-expression lentivirus 24 G. Genotyping 25 H. In vitro motor neuron differentiation 26 I. RNA extraction and reverse transcription-PCR 26 J. Semi-quantitative PCR and real-time PCR 28 K. Western blot 28 L. Alkaline phosphatase activity assay 30 M. Immunofluorescent staining and confocal microscopy 30 N. Statistical analysis 31 Results 33 PART I. Expression pattern of SMN during somatic cell reprogramming 33 PART II. Over-expression of SMN facilitates somatic cell reprogramming efficiency 37 PART III. SMA somatic cell performs lowered reprogramming efficiency and potency in iPS cell 39 PART IV. Over-expression of SMN affects pluripotent genes expression and neuronal differentiation in SMA-iPSCs 43 Discussion 63 Conclusions 69 Future Works 71 References 75 APPENDIX: Affidavit of Approval of Animal Use Protocol 86 | |
dc.language.iso | en | |
dc.title | 運動神經元存活蛋白於體細胞再程序化與神經分化角色之研究 | zh_TW |
dc.title | Roles of SMN in Somatic Cell Reprogramming and Neuronal Differentiation in the SMA Mouse Model | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-2 | |
dc.description.degree | 碩士 | |
dc.contributor.oralexamcommittee | 謝秀梅(Hsiu-Mei, Hsieh),李宣書(Hsuan-Shu, Lee),楊尚訓(Shang-Hsun, Yang) | |
dc.subject.keyword | 運動神經元存活蛋白,脊髓性肌肉萎縮症,誘導型多能性幹細胞,體細胞再程序化,神經分化, | zh_TW |
dc.subject.keyword | Survival motor neuron (SMN),spinal muscular atrophy (SMA),induced pluripotent stem cell (iPSC),somatic cell reprogramming,neuronal differentiation, | en |
dc.relation.page | 86 | |
dc.identifier.doi | 10.6342/NTU201702274 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2017-08-21 | |
dc.contributor.author-college | 生物資源暨農學院 | zh_TW |
dc.contributor.author-dept | 生物科技研究所 | zh_TW |
顯示於系所單位: | 生物科技研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 21.37 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。